[HTML][HTML] A prognostic nomogram of colon cancer with liver metastasis: a study of the US SEER database and a Chinese cohort

C Liu, C Hu, J Huang, K Xiang, Z Li, J Qu… - Frontiers in …, 2021 - frontiersin.org
Background Among colon cancer patients, liver metastasis is a commonly deadly
phenomenon, but there are few prognostic models for these patients. Methods The …

[HTML][HTML] Tumor sidedness influences prognostic impact of lymph node metastasis in colon cancer patients undergoing curative surgery

HW Lai, JCC Wei, HC Hung, CC Lin - Scientific Reports, 2019 - nature.com
This study aimed to evaluate prognostic impacts of the number of lymph nodes (LNs)
examined and LN ratio on cancer-specific mortality after surgery in patients with right-sided …

Postoperative complications predict long-term outcome after curative resection for perforated colorectal cancer

S Hashimoto, K Hamada, Y Sumida, M Araki, K Wakata… - in vivo, 2021 - iv.iiarjournals.org
Background/Aim: Perforation and postoperative complications have a negative effect on
long-term outcomes in patients with colorectal cancer (CRC). The aim of this study was to …

Examining more lymph nodes may improve the prognosis of patients with right colon cancer: Determining the optimal minimum lymph node count

W Wu, D Li, W Ma, S Zheng, D Han, F Xu… - Cancer …, 2021 - journals.sagepub.com
Objectives The objective is to determine the optimal minimum lymph node examination
number for right colon cancer (RCC) patients. Methods We comprehensively analysed the …

[PDF][PDF] Real-Life Experience of the Prognostic Significance of the Primary Tumor Location on the Timing of Colorectal Liver Metastases: A Retrospective Analysis

C Signorelli, PM Amodio, MG Chilelli, R Santoro… - Cureus, 2022 - cureus.com
Background Numerous research studies have looked into how the primary tumor location
(PTL) affects patients' prognosis for colorectal cancer (CRC). Our research aimed to …

Prognostic impact of tumour sidedness in patients with stage II colon cancer: a single‐centre retrospective study

K Iguchi, H Mushiake, T Fukushima… - ANZ Journal of …, 2021 - Wiley Online Library
Background The search for high‐risk factors in stage II colon cancer (CC) is ongoing and
several high‐risk factors for stage II CC have been identified; however, the effects of tumour …

Clinical Observation of mXELIRI and mFOLFIRI Combined with Cetuximab in First-line Treatment of Metastatic Left-side Colon Cancer

C Jianping, Z Xiaolin, LI Zhen, Y Mengyuan… - Cancer Research on …, 2020 - zlfzyj.com
Objective To compare the clinical efficacy and safety between mXELIRI and mFOLFIRI
combined with cetuximab in the first-line treatment of metastatic left-side colorectal cancer …

Tumor Sidedness Could be a High-risk Factor in Patients with Stage II Colon Cancer

K Iguchi, H Mushiake, S Hasegawa, D Inagaki… - 2020 - researchsquare.com
Background: The search for high-risk factors in stage II colon cancer (CC) is ongoing and
several high-risk factors for stage II CC have been identified; however, the effects of tumor …

mXELIRI 和 mFOLFIRI 方案联合西妥昔单抗一线治疗转移性左半结肠癌的临床观察

程建平, 赵晓琳, 李珍, 杨梦媛, 曹世长, 于久飞 - 肿瘤防治研究, 2020 - zlfzyj.com
摘要目的初步比较mXELIRI 与mFOLFIRI 方案联合西妥昔单抗一线治疗转移性左半结肠癌的
临床疗效及安全性. 方法回顾性分析68 例接受西妥昔单抗联合mXELIRI 或mFOLFIRI …